ENT

Olympus Offers New Portable Monitor for Single-Use Bronchoscopy and ENT Endoscopes

Retrieved on: 
Mercoledì, Maggio 1, 2024
Patient, System, Bronchoscopy, Digital video, ENT, HDMI, Workflow, Small Business Saturday, Nursing, Physician, Endoscopy, USB

The DVM-B2 Digital Video Monitor expands the single-use portfolio, which gives health care providers more choice in the patient care pathway.

Key Points: 
  • The DVM-B2 Digital Video Monitor expands the single-use portfolio, which gives health care providers more choice in the patient care pathway.
  • With the hybrid approach to endoscopy , healthcare providers have flexibility in their endoscopy solutions from one trusted endoscopy solutions partner.
  • Patients benefit from the convenience in terms of expanded sites of care and the availability of on-demand treatment options.
  • For use with the E-SteriScope™ Single-use Flexible Rhinolaryngoscopes, the DVM-B2 Digital Video Monitor supports streamlined content management and data sharing platforms such as the Olympus nCare™ recorder and VaultStream™ server.

Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million

Retrieved on: 
Giovedì, Aprile 25, 2024
FDA, Sinusitis, CS, ENT, Nose, Webcast, OPTN, Patient, MPH, Physician, Fluticasone, Ear, Telephone, Polyp (medicine), GAAP, Growth, Pharmaceutical industry

The Company will host an investor call at 10:00 a.m. Eastern Time today to discuss its commercial strategy and financial outlook.

Key Points: 
  • The Company will host an investor call at 10:00 a.m. Eastern Time today to discuss its commercial strategy and financial outlook.
  • In addition, the Company announced preliminary XHANCE net product revenue of $14.9 million for the three months ended March 31, 2024, representing growth of approximately 26% over the first quarter of 2023.
  • “The recent FDA approval of XHANCE as the first and only approved drug treatment for chronic sinusitis (CS) is a landmark achievement,” said Ramy Mahmoud, MD, MPH, CEO of Optinose.
  • In addition, a replay of the webcast will be available on the Company website for 60 days following the event.

ENT and Allergy Associates, LLP Welcomes Mark Boseley, MD to its Tarrytown Office

Retrieved on: 
Venerdì, Aprile 12, 2024
University, ENT, Suite, Nose, MD, Parent, CCC, Doctor of Audiology, Public health, Restaurant, Family, Patient, Sleepy, Gold, Pleasure, Otorhinolaryngology, Tulane University, Running, Northwell Health, Nursing

Dr. Boseley will begin serving patients full-time in ENTA’s Tarrytown, NY office located at 200 White Plains Road, Suite 201, Tarrytown, NY 10591.

Key Points: 
  • Dr. Boseley will begin serving patients full-time in ENTA’s Tarrytown, NY office located at 200 White Plains Road, Suite 201, Tarrytown, NY 10591.
  • Dr. Boseley's arrival affords the many young families and parents of Westchester County expanded access to expert pediatric otolaryngologic care.
  • Mark Boseley, M.D., joins ENTA from Mary Bridge Children’s Hospital in Tacoma, WA.
  • In the Tarrytown office, Dr. Boseley will join otolaryngologists Michael Bergstein, M.D., F.A.C.S., Cameron Budenz, M.D., Deya Jourdy, M.D., F.A.R.S., F.A.C.S., and Craig Zalvan, M.D., Allergist Mark Davis-Lorton, M.D., and Audiologists Jessica Comparetto, MA, CCC-A and Lucia Khoder, AuD, CCC-A.

Global Medical and Physician Scale Market Outlook & Forecast 2024-2029 with DETECTO, Seca, Shekel,TANITA, and Rice Lake Weighing Systems Dominating - ResearchAndMarkets.com

Retrieved on: 
Martedì, Aprile 16, 2024
Hospitals, Health, Surgery, Medical Devices, USD, Use, Practitioner, Malnutrition, Hospital, Safety, General surgery, Population growth, Nursing, ENT, Rice Lake Weighing Systems, Class, Intake, Growth, European, Medical device, Body composition, Patient, Classification, Acquisition, Ease, Diagnosis, Ageing, MDD, Prevalence, Pharmaceutical industry

The "Global Medical and Physician Scale Market - Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Medical and Physician Scale Market - Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.
  • Companies prioritize mergers and acquisitions to increase their industry share and bolster sales in the current global medical and physician scale market landscape.
  • North America holds the most prominent share of the global medical and physician scale market, accounting for over 27% in 2023.
  • The global medical and physician scale market by product is segmented into floor scale, infant/baby scale, chair scale, body fat scale, and others.

ModMed® Ranks #1 for Integrated Practice Management, Revenue Cycle Management and EHR in Surgical Specialties by Black Book Research for Sixth Consecutive Year

Retrieved on: 
Martedì, Aprile 16, 2024
Health Technology, Health Insurance, Data Management, Technology, Finance, Consulting, Surgery, Practice Management, Managed Care, Professional Services, Hospitals, Artificial Intelligence, Software, Data Analytics, Health, Electronic health record, Gastroenterology, Revenue cycle management, Ophthalmology, ENT, EHR, Urology, Dermatology, OBGYN, Senior, Pain management, Face, Practice management software, Multimedia, Allergy, Podiatry, Nursing

Specialty-specific healthcare technology leader ModMed® today announced its #1 ranking by Black Book™ Research for the sixth year in a row for Integrated Practice Management, Revenue Cycle Management and Electronic Health Record (EHR) in Surgical Specialties.

Key Points: 
  • Specialty-specific healthcare technology leader ModMed® today announced its #1 ranking by Black Book™ Research for the sixth year in a row for Integrated Practice Management, Revenue Cycle Management and Electronic Health Record (EHR) in Surgical Specialties.
  • "We are thrilled that ModMed has been recognized as the top provider of comprehensive solutions for the sixth year in a row.
  • Our solutions go beyond the traditional boundaries, fostering collaborative environments that enhance efficiency and performance," said Rob Ware, Senior Vice President of Revenue Cycle Management at ModMed.
  • Raman Mahabir, MD at Tucson Plastic Surgery, LLC, uses ModMed’s integrated Practice Management and EHR solutions at his practice.

ModMed & Medtronic Collaborate to Drive Efficiencies in Documenting Colonoscopies Using AI

Retrieved on: 
Mercoledì, Aprile 10, 2024
Surgery, General Health, Health, Artificial Intelligence, Medical Devices, Hospitals, Health Technology, Technology, Cancer, Endoscopy, Capital, AI, ENT, Thought, EHR, Artificial intelligence, Polyp (medicine), Medtronic, Documentation, Patient, Physician, Colonoscopy, Multimedia, Nursing

Practice technology leader and EHR pioneer ModMed ® announced today that it will collaborate with Medtronic, the world’s largest medtech company, to enhance the documentation of polyp detection by utilizing the AI capabilities of the GI Genius system sold by Medtronic.

Key Points: 
  • Practice technology leader and EHR pioneer ModMed ® announced today that it will collaborate with Medtronic, the world’s largest medtech company, to enhance the documentation of polyp detection by utilizing the AI capabilities of the GI Genius system sold by Medtronic.
  • View the full release here: https://www.businesswire.com/news/home/20240410782785/en/
    Practice technology leader and EHR pioneer ModMed® announced today that it will collaborate with Medtronic, the world’s largest medtech company, to enhance the documentation of polyp detection by utilizing the AI capabilities of the GI Genius system sold by Medtronic.
  • ModMed supports this goal and believes that additional efficiency can be built into the colonoscopy process.
  • "Our goal is to ensure that physicians have more time to focus on patients by building efficiency into the documentation process.

PRESBYTERIAN HEALTH PLAN AND NEW MEXICO ONCOLOGY HEMATOLOGY CONSULTANTS PARTNER ON NEW CONTRACT TO EXPAND ACCESS TO CARE

Retrieved on: 
Martedì, Aprile 16, 2024
Rheumatology, ENT, Patient, Insurance, Travel, PHP, Urology, General surgery, Nursing

ALBUQUERQUE, N.M. , April 16, 2024 /PRNewswire/ -- Presbyterian Health Plan (PHP) and New Mexico Oncology Hematology Consultants Ltd. (NMOHC) are pleased to announce a new contract effective April 1, 2024, that expands access to care for oncology patients and those seeking specialty services in New Mexico.

Key Points: 
  • ALBUQUERQUE, N.M. , April 16, 2024 /PRNewswire/ -- Presbyterian Health Plan (PHP) and New Mexico Oncology Hematology Consultants Ltd. (NMOHC) are pleased to announce a new contract effective April 1, 2024, that expands access to care for oncology patients and those seeking specialty services in New Mexico.
  • This agreement eliminates the need for NMOHC patients with PHP insurance to travel to other locations for covered services.
  • "This improved access allows patients to receive essential care more conveniently," explains Dr. Barbara McAneny, CEO of New Mexico Oncology Hematology Consultants Ltd. "Our comprehensive practice offers a wide range of services, including oncology, pulmonology, urology, ENT, rheumatology, and general surgery, all under one roof."
  • "We have worked closely with NMOHC on a contract solution that we think benefits the people we jointly serve," said Brandon Fryar, president of Presbyterian Health Plan.

Verana Health to Reveal Results from Largest Pediatric Intraocular Lens Study, Funded by the FDA, During AAPOS 2024

Retrieved on: 
Martedì, Aprile 9, 2024
Device, Intraocular lens, IOL, CDRH, Health equity, Partnership, Patient, SAN, Research, American Academy, Manuscript, MD, ENT, Quality, Safety, FDA, Cataract, Food, Medicine, Dentistry

Verana Health led the analysis utilizing real-world data from the Academy IRIS Registry – one of the largest specialty society clinical data registries in all of medicine.

Key Points: 
  • Verana Health led the analysis utilizing real-world data from the Academy IRIS Registry – one of the largest specialty society clinical data registries in all of medicine.
  • “The results of this study underscore the transformative potential of high-quality, curated real-world data in generating real-world evidence to enhance treatments and improve patients’ lives,” said Sujay Jadhav, CEO of Verana Health.
  • “We thank the FDA for the opportunity to lead this study, and we extend our appreciation to the Academy for its partnership.
  • Verana Health utilized its clinician-directed and artificial intelligence-enhanced population health data engine, VeraQ ®, to analyze curated, de-identified IRIS Registry data on pediatric cataract surgeries, amplifying the depth and accuracy of the study's insights.

Lead Real Estate Co., Ltd ENT TERRACE AKIHABARA Hotel Recognized for Booking.com’s Traveller Review Awards 2024

Retrieved on: 
Lunedì, Aprile 8, 2024
Travel, Electronics, Booking.com, ENT, Safety, LRE, Tokyo City, Hotel

Booking.com’s Traveller Awards is an esteemed list of international properties based on over 308 million customer reviews.

Key Points: 
  • Booking.com’s Traveller Awards is an esteemed list of international properties based on over 308 million customer reviews.
  • The final review score was calculated on December 1, 2023, based on reviews received in the previous three years.
  • “Our ENT TERRACE AKIHABARA property, which opened to customers in February 2023, demonstrates our continued dedication to developing exceptional properties and experiences for long-term travel.
  • This is the second hotel that the Company has developed for the ENT TERRACE brand, with the other one located in Asakusa.

Optinose to Present at the Needham Virtual Healthcare Conference

Retrieved on: 
Giovedì, Aprile 4, 2024
Nose, Webcast, Patient, Ear, OPTN, Conference, ENT, Broadcasting

YARDLEY, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the Needham Virtual Healthcare Conference on April 10, 2024 at 2:15 p.m.

Key Points: 
  • YARDLEY, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the Needham Virtual Healthcare Conference on April 10, 2024 at 2:15 p.m.
  • ET.
  • To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.
  • A replay of the webcast will be available for 30 days following the conclusion of the event.